Basic Principles of Virion Formation
The formation of new viral particles occurs during the final stage of intracellular development. The driving force behind this process is self-assembly (or auto-assembly). Synthesized viral components are directionally transported to specific zones within the infected cell, which may include the cytoplasm or the nucleus.
The joining of viral components is based on strict physicochemical principles:
- Steric fit: Elements match each other in shape (the principle of complementarity), allowing precise docking.
- Types of interaction: The integration of structures is secured by non-covalent bonds (hydrophobic, ionic, and hydrogen bonds).
- Cascade process: Assembly does not happen instantaneously. It is a multistep process during which intermediate structures form first. In terms of their polypeptide composition, these transitory forms differ significantly from fully assembled, mature viral particles.
Differences in Assembly Between Non-Enveloped and Enveloped Viruses
The mechanics of assembly directly depend on the architecture of the future virion.
Non-enveloped viruses (lacking a lipoprotein envelope) form via direct protein-nucleic acid interactions. Viral nucleic acids tightly bind to capsid proteins. The result of this stage is the formation of a nucleocapsid, which for non-enveloped viruses already constitutes a fully mature and infectious particle.
Enveloped viruses assemble in two sequential stages:
- First, analogous to non-enveloped viruses, an internal nucleocapsid is formed.
- Next, the nucleocapsid interacts with cellular membranes (which the virus has previously modified for its needs) to create the outer lipoprotein envelope, or envelope/supercapsid.
The site of assembly for enveloped virions is dictated by their replication site. If replication occurs in the nucleus, the envelope is formed with the participation of the nuclear membrane. If the process takes place in the cytoplasm, the building blocks are derived from the endoplasmic reticulum (ER) membranes or the plasma membrane, into which specific viral glycoproteins have been pre-embedded.
A special role in several negative-sense single-stranded RNA viruses (e.g., Paramyxoviridae and Orthomyxoviridae) is played by the matrix protein (M-protein). It acts as a molecular bridge: linking the formed nucleocapsid to viral glycoproteins already integrated into the cell membrane, thereby triggering the budding process.
Mechanisms of Progeny Release
The egress of virions is the final chord of replication, which dictates the future fate of the infected cell. There are two primary pathways.
1. Lytic Release (Burst Mechanism)
This scenario is typical for non-enveloped viruses. A simultaneous, massive release of a huge number of accumulated virions into the extracellular space occurs. The consequences for the host cell are fatal: it undergoes rapid destruction and dies.
2. Budding (Exocytosis)
This mechanism is characteristic of enveloped viruses. During budding, the outer viral envelope is constructed from patches of modified cellular membrane. The process proceeds step-by-step:
- The nucleocapsid is transported to the membrane.
- Virus-specific proteins integrate into the cell membrane.
- The nucleocapsid establishes tight contact with this prepared site.
- The membrane bulges outward followed by the pinching off ("budding") of the mature enveloped virion.
During budding, the cell is not destroyed instantaneously. It can maintain viability for a long time, acting as a factory for the continuous production of viral progeny.
Where does budding occur? This depends on the viral family:
- Through the plasma membrane: Typical for viruses whose assembly occurs in the cytoplasm (Togaviridae, Paramyxoviridae).
- Through ER membranes: The virus buds into cisternae and is then transported to the surface (Bunyaviridae).
- Through the nuclear membrane: Characteristic of viruses that assemble in the nucleus (Herpesviridae). They bud into the perinuclear space, acquire an envelope there, and are then transported to the cell surface via cytoplasmic vesicles.